Irritable bowel syndrome genophenomics: correlation of serotonin-transporter polymorphisms and alosetron response
- 1 January 2003
- journal article
- editorial
- Published by Springer Nature in The Pharmacogenomics Journal
- Vol. 3 (2) , 64-66
- https://doi.org/10.1038/sj.tpj.6500163
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Full-thickness biopsy of the jejunum reveals inflammation and enteric neuropathy in irritable bowel syndromeGastroenterology, 2002
- IRRITABLE-INFLAMMATORY BOWEL DISEASE: RECOGNIZING A NEW OVERLAP SYNDROME AND AN ENIGMA WRAPPED INSIDE A PUZZLEInflammatory Bowel Diseases, 2002
- Serotonin-transporter polymorphism pharmacogenetics in diarrhea-predominant irritable bowel syndromeGastroenterology, 2002
- Unravelling the disease processThe Lancet, 2001
- The Sequence of the Human GenomeScience, 2001
- Initial sequencing and analysis of the human genomeNature, 2001
- Efficacy and safety of alosetron in women with irritable bowel syndrome: a randomised, placebo-controlled trialThe Lancet, 2000
- Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort studyBMJ, 1999
- Alterations in Enteric Nerve and Smooth-Muscle Function in Inflammatory Bowel DiseasesInflammatory Bowel Diseases, 1997
- Nitric Oxide Synthase Activity in Infantile Hypertrophic Pyloric StenosisNew England Journal of Medicine, 1992